Aix Scientifics®   Clinical Research Organisation

Current projects i.a.

  • ABGEL-Project / ERDF In the ABGEL project, a temporary spacer is being developed
    to shield organs during the radiotherapy of carcinomas.
    Aix Scientifics® is responsible for preclinical research in this project.
    The Project is supported by
  • APPIRED III study / MEDUWA .
    Pharmaceuticals in the aquatic environment endanger the water quality.
    The Dutch / German MEDUWA project addresses this problem.
    Aix Scientifics® participates in this project with the APPIRED III-Studie.
    The Project is supported by

Aix Scientifics® has experiences in Clinical Research

  • At present we are accompanying clinical studies all around the world
  • including patient numbers of two to four digits.
  • Usually these are prospective phase III pivotal studies;
  • others are phase IV studies or post-marketing surveillances,
  • retrospective studies, producer-independent studies or registries.
  • Clients are producers of drugs or medical devices as well as professional associations.
  • Most studies are international, multilingual and Internet-supported.
Products under investigation
  •   Pharmaceutical Products
  • Antibiotics
  • Immunotherapeutics
  • Wound therapeutics
  • Neuro-psychiatric medication
  • Contrast media
  •   Medical Devices
  • Ablation devices
  • Joint implants
  • Heart valves
  • Intracardiac pumps and VADs
  • Vessel prostheses and stents
  • Gels and meshes
  • VSD Occluder
  • Wound therapeutics
  • Cell separators
  • Aix Scientifics® has been working for sponsors from :

    • Egypt, Germany , Switzerland , The Netherlands , United Kingdom , Italy ,
      United States of America and Russia.

    Publications based on study results of Aix Scientifics® :

    URL: https://aix-scientifics.it/en/experience.html     ( QR | DM  code ) (vCard) [printed: 05.02.2023 15:38]
    Copyright © 1996-2023   Aix Scientifics® CRO, Aix (Aachen), Fed.Rep.Germany (last revision : 19th of April 2021)
    Imprint | Policy